Top

Published in:

01-12-2011 | Review

Year in review 2010: Critical Care- infection

Authors: Leonardo Pagani, Arash Afshari, Stephan Harbarth

Published in: Critical Care | Issue 6/2011

Abstract

Infections remain among the most important concerns in critically ill patients. Early and reliable diagnosis of infection still poses difficulties in this setting but also represents a crucial step toward appropriate antimicrobial therapy. Increasing antimicrobial resistance challenges established approaches to the optimal management of infections in the intensive care unit. Rapid infection diagnosis, antibiotic dosing and optimization through pharmacologic indices, progress in the implementation of effective antimicrobial stewardship and infection control programs, and management of fungal infections are some of the most relevant issues in this special patient population. During the last 18 months, Critical Care and other journals have provided a wide array of descriptive and interventional clinical studies and scientific reports helping clinical investigators and critical care physicians to improve diagnosis, management, and therapy of infections in critically ill patients.

Harbarth S, Haustein T: Year in review 2009: Critical Care--infection. Crit Care. 2010, 14: 240-10.1186/cc9268.PubMedCentralCrossRefPubMed

Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA, Fanconi S: Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis. 2004, 38: 1383-1390. 10.1086/420741.CrossRefPubMed

Leggieri N, Rida A, François P, Schrenzel J: Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis. 2010, 23: 311-319.PubMed

Mancini N, Carletti S, Ghidoli N, Cichero P, Burioni R, Clementi M: The era of molecular and other non-culture-based methods in diagnosis of sepsis. Clin Microbiol Rev. 2010, 23: 235-251. 10.1128/CMR.00043-09.PubMedCentralCrossRefPubMed

Tissari P, Zumla A, Tarkka E, Mero S, Savolainen L, Vaara M, Aittakorpi A, Laakso S, Lindfors M, Piiparinen H, Maki M, Carder C, Huggett J, Gant V: Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet. 2010, 375: 224-230. 10.1016/S0140-6736(09)61569-5.CrossRefPubMed

Dark PM, Dean P, Warhurst G: Bench-to-bedside review: the promise of rapid infection diagnosis during sepsis using polymerase chain reaction-based pathogen detection. Crit Care. 2009, 13: 217-10.1186/cc7886.PubMedCentralCrossRefPubMed

Yanagihara K, Kitagawa Y, Tomonaga M, Tsukasaki K, Kohno S, Seki M, Sugimoto H, Shimazu T, Tasaki O, Matsushima A, Ikeda Y, Okamoto S, Aikawa N, Hori S, Obara H, Ishizaka A, Hasegawa N, Takeda J, Kamihira S, Sugahara K, Asari S, Murata M, Kobayashi Y, Ginba H, Sumiyama Y, Kitajima M: Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care. 2010, 14: R159-10.1186/cc9234.PubMedCentralCrossRefPubMed

Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P: Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic use and bacterial resistance, 2001 to 2008. Crit Care. 2010, 14: R113-10.1186/cc9062.PubMedCentralCrossRefPubMed

Schuetz P, Wolbers M, Christ-Crain M, Thomann R, Falconnier C, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Morgenthaler NG, Schoenenberg R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher HC, Zimmerli W, Mueller B, for the ProHOSP Study Group: Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections. Crit Care. 2010, 14: R106-10.1186/cc9055.PubMedCentralCrossRefPubMed

10.

Kibe S, Adams K, Barlow G: Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011, 66 (S2): ii33-40.PubMed

11.

Christ-Crain M, Opal SM: Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care. 2010, 14: 203-10.1186/cc8155.PubMedCentralCrossRefPubMed

12.

Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008, 177: 498-505.CrossRefPubMed

13.

Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, PRORATA Trial Group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010, 375: 463-474. 10.1016/S0140-6736(09)61879-1.CrossRefPubMed

14.

van Nieuwkoop C, Bonten TN, van't Wout JW, Kuijper EJ, Groenveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EMS, van Dissel JT: Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care. 2010, 14: R206-10.1186/cc9328.PubMedCentralCrossRefPubMed

15.

Pea F, Viale P, Furlanut M: Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet. 2005, 44: 1009-1034. 10.2165/00003088-200544100-00002.CrossRefPubMed

16.

Giannoni E, Moreillon P, Cotting J, Moessinger A, Bille J, Décosterd L, Zanetti G, Majcherczyk P, Bugnon D: Prospective determination of plasma imipenem concentrations in critically ill children. Antimicrob Agents Chemother. 2006, 50: 2563-2568. 10.1128/AAC.01149-05.PubMedCentralCrossRefPubMed

17.

Pea F, Viale P: Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?. Crit Care. 2009, 13: 214-10.1186/cc7774.PubMedCentralCrossRefPubMed

18.

Choi EY, Hun JW, Lim C-M, Koh Y, Kim S-H, Choi S-H, Kim YS, Kim M-N, Hong S-B: Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med. 2011, 37: 639-647. 10.1007/s00134-011-2130-7.CrossRefPubMed

19.

Taccone FS, Laterre P-F, Spapen H, Dugernier T, Delattre I, Layeux B, De Backer D, Wittebole X, Wallemacq P, Vincent J-L, Jacobs F: Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care. 2010, 14: R53-10.1186/cc8945.PubMedCentralCrossRefPubMed

20.

Layeux B, Taccone FS, Fagnoul D, Vincent JL, Jacobs F: Amikacin monotherapy for sepsis caused by panresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010, 54: 4939-4941. 10.1128/AAC.00441-10.PubMedCentralCrossRefPubMed

21.

Gálvez R, Luengo C, Cornejo R, Kosche J, Romero C, Tobar E, Illanes V, Llanos O, Castro J: Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. Int J Antimicrob Agents. 2011, 38: 146-151. 10.1016/j.ijantimicag.2011.03.022.CrossRefPubMed

22.

Taccone FS, de Backer D, Laterre P-F, Spapen H, Dugernier T, Delattre I, Wallemacq P, Vincent J-L, Jacobs F: Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy. Int J Antimicrob Agents. 2011, 37: 531-535. 10.1016/j.ijantimicag.2011.01.026.CrossRefPubMed

23.

Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J: Augmented renal clearance. Implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010, 49: 1-16. 10.2165/11318140-000000000-00000.CrossRefPubMed

24.

Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent J-L, Jacobs F: Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care. 2011, 15: R137-10.1186/cc10257.PubMedCentralCrossRefPubMed

25.

Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J: A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care. 2011, 15: R139-10.1186/cc10262.PubMedCentralCrossRefPubMed

26.

Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP: Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med. 2011, 37: 632-638. 10.1007/s00134-010-2105-0.CrossRefPubMed

27.

Taccone FS, Laterre P-F, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Wallemacq P, Vincent J-L, Jacobs F: Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010, 14: R126-10.1186/cc9091.PubMedCentralCrossRefPubMed

28.

Hayashi Y, Roberts JA, Paterson DL, Lipman J: Pharmacokinetic evaluation of piperacillin-tazobactam. Expert Opin Drug Metab Toxicol. 2010, 6: 1017-1031. 10.1517/17425255.2010.506187.CrossRefPubMed

29.

Lodise TP, Drusano GL: Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit. Crit Care Clin. 2011, 27: 1-18. 10.1016/j.ccc.2010.11.003.CrossRefPubMed

30.

Lodise TP, Butterfield J: Use of pharmacodynamic principles to inform β-lactam dosing: 'S' does not always mean success. J Hosp Med. 2011, 6 (Suppl 1): S16-S23.CrossRefPubMed

31.

Lodise TP, Sorgel F, Melnick D, Mason B, Kinzig M, Drusano GL: Penetration of meropenem into epithelial lining fluid of patients with ventilator-associated pneumonia. Antimicrob Agents Chemother. 2011, 55: 1606-1610. 10.1128/AAC.01330-10.PubMedCentralCrossRefPubMed

32.

Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J: The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet. 2011, 50: 99-110. 10.2165/11539220-000000000-00000.CrossRefPubMed

33.

Chapuis TM, Giannoni E, Majcherczyk PA, Chioléro R, Schaller M-D, Berger MM, Bolay S, Décosterd LA, Bugnon D, Moreillon P: Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care. 2010, 14: R51-10.1186/cc8941.PubMedCentralCrossRefPubMed

34.

Adembri C, Novelli A: Pharmacokinetic and pharmacodynamic parameters of antimicrobials. Potential for providing dosing regimens that are less vulnerable to resistance. Clin Pharmacokinet. 2009, 48: 517-528. 10.2165/10895960-000000000-00000.CrossRefPubMed

35.

Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A: Society's failure to protect a precious resource: antibiotics. Lancet. 2011, 378: 369-371. 10.1016/S0140-6736(11)60401-7.CrossRefPubMed

36.

Morel J, Casoetto J, Jospé R, Aubert G, Terrana R, Dumont A, Molliex S, Auboyer C: De-escalation as part of global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit. Crit Care. 2010, 14: R225-10.1186/cc9373.PubMedCentralCrossRefPubMed

37.

Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanèse J, Martin C: Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med. 2007, 35: 379-385. 10.1097/01.CCM.0000253404.69418.AA.CrossRefPubMed

38.

Dellit TH, Chan JD, Skerret SJ, Nathens AB: Development of a guideline for the management of ventilator-associated pneumonia based on local microbiological findings and impact of the guidelines on antimicrobial use practices. Infect Control Hosp Epidemiol. 2008, 29: 525-533. 10.1086/588160.CrossRefPubMed

39.

Pagani L, Falciani M, Aschbacher R: Use of microbiologic findings to manage antimicrobials in the intensive care unit. Infect Control Hosp Epidemiol. 2009, 30: 309-311. 10.1086/595731.CrossRefPubMed

40.

Raineri E, Pan A, Mondello P, Acquarolo A, Candiani A, Crema L: Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control. 2008, 36: 283-290. 10.1016/j.ajic.2007.06.009.CrossRefPubMed

41.

Augustin P, Kermarrec N, Muller-Serieys C, Lasocki S, Chosidow D, Marmuse J-P, Valin n, Desmonts J-M, Montravers P: Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis. Crit Care. 2010, 14: R20-10.1186/cc8877.PubMedCentralCrossRefPubMed

42.

Owens RC: Antimicrobial stewardship: application in the intensive care unit. Infect Dis Clin North Am. 2009, 23: 683-702. 10.1016/j.idc.2009.04.015.CrossRefPubMed

43.

Lawrence KL, Kollef MH: Antimicrobial stewardship in the intensive care unit. Advances and obstacles. Am J Respir Crit Care Med. 2009, 179: 434-438. 10.1164/rccm.200809-1394CP.CrossRefPubMed

44.

Prospero E, Barbadoro P, Esposto E, Manso E, Martini E, Savini S, Scaccia F, Tantucci L, Pelaia P, D'Errico MM: Extended-spectrum beta-lactamases Klebsiella pneumoniae: multimodal infection control program in intensive care units. J Prev Med Hyg. 2010, 51: 110-115.PubMed

45.

Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, Render ML, Fryberg RW, Jernigan JA, Muder RR, Miller LJ, Roselle GA: Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011, 364: 1419-1430. 10.1056/NEJMoa1007474.CrossRefPubMed

46.

Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sincowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, for the STAR*ICU Trial Investigators: Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011, 364: 1407-1418. 10.1056/NEJMoa1000373.PubMedCentralCrossRefPubMed

47.

Tamma PD, Cosgrove SE: Antimicrobial stewardship. Infect Dis Clin North Am. 2011, 25: 245-260. 10.1016/j.idc.2010.11.011.CrossRefPubMed

48.

George P, Morris AM: Pro/con debate: should antimicrobial stewardship programs be adopted universally in the intensive care unit?. Crit Care. 2010, 14: 205-10.1186/cc8219.PubMedCentralCrossRefPubMed

49.

Morace G, Borghi E: Fungal infections in ICU patients: epidemiology and the role of diagnostics. Minerva Anestesiol. 2010, 76: 950-956.PubMed

50.

Bassetti M, Mikulska M, Viscoli C: Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit. Crit Care. 2010, 14: 244-10.1186/cc9239.PubMedCentralCrossRefPubMed

51.

Leroy O, Mira J-P, Montravers P, Gangneux J-P, Lortholary O, for the AmarCand Study Group: Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care. 2010, 14: R98-10.1186/cc9033.PubMedCentralCrossRefPubMed

52.

Trof RJ, Beishuizen A, Debets-Ossenkopp YP, Girbes AR, Groeneveld AB: Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007, 33: 1694-1703. 10.1007/s00134-007-0791-z.PubMedCentralCrossRefPubMed

53.

He H, Ding L, Li F, Zhan Q: Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study. Crit Care. 2011, 15: R5-10.1186/cc9402.PubMedCentralCrossRefPubMed

54.

Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, Vachon J, Gonzales C, Hongjie Y, Zijian F, Chuang SK, Au A, Buda S, Krause G, Haas W, Bonmarin I, Taniguichi K, Nakajima K, Shobayashi T, Takayama Y, Sunagawa T, Heraud JM, Orelle A, Palacios E, van der Sande MAB, Lieke Wielders CCH, et al: Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011, 8: e1001053-10.1371/journal.pmed.1001053.PubMedCentralCrossRefPubMed

55.

Kuster SP, Katz KC, Blair J, Downey J, Drews SJ, Finkelstein S, Fowler R, Green K, Gubbay J, Hassan K, Lapinsky SE, Mazzulli T, McRitchie D, Pataki J, Plevneshi A, Powis J, Rose D, Sarabia A, Simone C, Simor A, McGeer A: When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results from population-based active surveillance in Toronto. Crit Care. 2011, 15: R182-10.1186/cc10331.PubMedCentralCrossRefPubMed

56.

Han K, Ma H, An X, Su Y, Chen J, Lian Z, Zhao J, Zhu BP, Fontaine RE, Feng Z, Zeng G: Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis. 2011, 53: 326-333. 10.1093/cid/cir398.CrossRefPubMed

Title: Year in review 2010: Critical Care- infection
Authors: Leonardo Pagani
Arash Afshari
Stephan Harbarth
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Critical Care / Issue 6/2011
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc10425

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Year in review 2010: Critical Care- infection

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Dipyridamole augments the antiinflammatory response during human endotoxemia

Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool

Risk factors for invasive fungal disease in critically ill adult patients: a systematic review

Atypical antipsychotics and delirium in critical care

Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study

Do fluctuations of PaCO2 impact on the venous-arterial carbon dioxide gradient?